Victory Capital Management’s Palisade Bio PALI Stock Holding History
Bought
Maintained
Sold
Other funds holding PALI
BGI
Victory Capital Management's PALI Position: Q3 2026 in Review
Victory Capital Management reduced its Palisade Bio (PALI) stake by 4.9% in Q3 2026, selling an estimated $1.88K and leaving 18,792 shares worth $25.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2482.
Victory Capital Management first reported a position in PALI in Q4 2025 and has held it in 4 quarters since. The position peaked at $41.3K in Q2 2026. 116 funds tracked by Wall St. Rank hold PALI as of Q3 2026.
- Victory Capital Management held 18,792 shares of Palisade Bio worth $25.4K as of Q3 2026.
- Victory Capital Management sold 965 Palisade Bio shares in Q3 2026, an estimated $1.88K.
- Palisade Bio made up ﹤0.01% of Victory Capital Management's portfolio in Q3 2026, its #2482 holding.
- Victory Capital Management first reported a position in Palisade Bio in Q4 2025 and has held it in 4 quarters since.
- Victory Capital Management's Palisade Bio position peaked at $41.3K in Q2 2026.
- 116 funds tracked by Wall St. Rank held Palisade Bio as of Q3 2026.
Based on Victory Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.